2 Biotech Companies That Might Be on Pfizer's Radar Right Now

2 Biotech Companies That Might Be on Pfizer's Radar Right Now

Source: 
Motley Fool
snippet: 

  • Pfizer is on the cusp of a major spending spree.
  • Adaptimmune Therapeutics would give the pharma giant a potentially best-in-class cell therapy platform.
  • Affimed's unique approach to ramping up the innate immune system makes it an intriguing takeover target.